Copeptin does not accurately predict disease severity in imported malaria

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Van Wolfswinkel, Marlies E ^a   Hesselink, Dennis A ^b   Hoorn, Ewout J ^b   De Rijke, Yolanda B ^b   Koelewijn, Rob ^a   Van Hellemond, Jaap J ^a,b   Van Genderen, Perry Jj ^a  

^a Harbour Hospital   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Arginine vasopressin; Biomarkers; C reactive protein; Copeptin; CRP; Imported; Malaria; Severity; Traveller

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; COPEPTIN; GLUCOSE; HEMOGLOBIN; LACTIC ACID; PROCALCITONIN; SODIUM; UNCLASSIFIED DRUG; UREA; GLYCOPEPTIDE;

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; LACTATE BLOOD LEVEL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PLASMODIUM MALARIAE INFECTION; PLASMODIUM OVALE MALARIA; PLASMODIUM VIVAX MALARIA; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SODIUM BLOOD LEVEL; THROMBOCYTE COUNT; UREA BLOOD LEVEL; BLOOD; CHEMISTRY; COMPARATIVE STUDY; EVALUATION; HOSPITALIZATION; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; SERUM;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHILD; FEMALE; GLYCOPEPTIDES; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SERUM; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84855361589     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-6     Document Type: Article

References (16)

1. Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients. Struck J, Morgenthaler NG, Bergmann A, Peptides 2005 26 2500 2504 10.1016/j.peptides.2005.04.019 15922490 (Pubitemid 41676723)
2. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Morgenthaler NG, Struck J, Alonso C, Bergmann A, Clin Chem 2006 52 112 119 10.1373/clinchem.2005.060038 16269513 (Pubitemid 43032474)
3. Copeptin and arginine vasopressin concentrations in critically ill patients. Jochberger S, Morgenthaler NG, Mayr VD, Luckner G, Wenzel V, Ulmer H, Schwarz S, Hasibeder WR, Friesenecker BE, Dünser MW, J Clin Endocrinol Metab 2006 91 4381 4386 10.1210/jc.2005-2830 16940457 (Pubitemid 44833413)
4. Copeptin as a predictor of disease severity and survival in leptospirosis. Limper M, Goeijenbier M, Wagenaar JF, Gasem MH, Isbandrio B, Kunde J, Hartmann O, Duits AJ, Van Gorp EC, J Infect 2010 6 92 94
5. Altered fluid, electrolyte and mineral status in tropical disease, with an emphasis on malaria and leptospirosis. Sitprija V, Nat Clin Pract Nephrol 2008 4 91 101 18227802 (Pubitemid 351185784)
6. Hyponatremia in severe malaria: evidence for an appropriate antidiuretic hormone response to hypovolemia. Hanson J, Hossain A, Charunwatthana P, Hassan MU, Davis TM, Lam SW, Chubb SA, Maude RJ, Yunus EB, Haque G, White NJ, Day NP, Dondorp AM, Am J Trop Med Hyg 2009 80 141 145 19141852
7. Plasma and urine electrolyte concentrations and vasopressin levels in patients admitted to hospital for falciparum malaria. Fryatt RJ, Teng JD, Harries AD, Moody AH, Hall AP, Forsling ML, Trop Geogr Med 1989 41 57 60 2669290 (Pubitemid 19217648)
8. Inappropriate secretion of antidiuretic hormone and hyponatremia in severe falciparum malaria. Holst FG, Hemmer CJ, Kern P, Dietrich M, Am J Trop Med Hyg 1994 50 602 607 8203710 (Pubitemid 24196350)
9. Hyponatraemia in imported malaria is common and associated with disease severity. van Wolfswinkel ME, Hesselink DA, Zietse R, Hoorn EJ, van Genderen PJ, Malar J 2010 25 140
10. Improving case definitions for severe malaria. Anstey NM, Price RN, PLoS Med 2007 4 267 10.1371/journal.pmed.0040267 17713984 (Pubitemid 47358161)
11. Evaluation of plasma lactate as a parameter for disease severity on admission in travelers with Plasmodium falciparum malaria. Van Genderen PJ, van der Meer IM, Consten J, Petit PLC, van Gool T, Overbosch D, J Travel Med 2005 12 261 264 16256049 (Pubitemid 43074387)
12. Procalcitonin as a biomarker for severe Plasmodium falciparum disease: a critical appraisal of a semi-quantitative point-of-care test in a cohort of travellers with imported malaria. Hesselink DA, Burgerhart JS, Bosmans-Timmerarends H, Petit P, van Genderen PJ, Malar J 2009 8 206 10.1186/1475-2875-8-206 19723338
13. Neopterin and procalcitonin are suitable biomarkers for exclusion of severe Plasmodium falciparum disease at the initial clinical assessment of travellers with imported malaria. te Witt R, van Wolfswinkel ME, Petit PL, van Hellemond JJ, Koelewijn R, van Belkum A, van Genderen PJ, Malar J 2010 9 255 10.1186/1475-2875-9-255 20840738
14. Guidelines for the treatment of malaria. World Health Organization Second 2010 http://www.who.int/malaria/publications/atoz/9789241547925/en/index.html
15. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. DeLong ER, DeLong DM, Clarke-Pearson DL, Biometrics 1988 44 837 845 10.2307/2531595 3203132
16. Severe imported falciparum malaria: a cohort study in 40 critically ill adults. Bruneel F, Tubach F, Corne P, Megarbane B, Mira JP, Peytel E, Camus C, Schortgen F, Azoulay E, Cohen Y, Georges H, Meybeck A, Hyvernat H, Trouillet JL, Frenoy E, Nicolet L, Roy C, Durand R, Le Bras J, Wolff M, PLoS One 2010 5 13236 10.1371/journal.pone.0013236 20949045